Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma

Eric C. Vonderheid(Ashford and St Peter's Hospitals NHS Foundation Trust), Eugene J. Van Scott(Philadelphia University), Larry Shrager(Philadelphia University), Elizabeth T. Tan(Philadelphia University), Bizhan Micaily(Philadelphia University), Arlene F. Kantor(Philadelphia University)
Journal of the American Academy of Dermatology
March 1, 1989
10.1016/s0190-9622(89)70051-7
Cited by 259

Related Papers

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
|Blood|2007|1.4k
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
|New England Journal of Medicine|1987|1.2k
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610
Defining early mycosis fungoides
|Journal of the American Academy of Dermatology|2005|543